Ex Parte WATANABE et al - Page 11




          Appeal No. 1998-2190                                                        
          Application No. 08/593,266                                                  


          i.e., Tada.  See In re Burckel, 592 F.2d 1175, 1179, 201 USPQ 67,           
          71 (CCPA 1979).  We note that Tada discloses an example with indium         
          sulfate while the comparative tests only compare indium sulfate,            
          sulfamate, and chloride against no indium compound or indium oxide          
          (specification, pages 32-35).  Furthermore, appellants have not             
          explained why the comparative results are commensurate in scope             
          with the claims.  See In re Boesch, 617 F.2d 272, 276, 205 USPQ             
          215, 219 (CCPA 1980).  The claims are quite broad in scope while            
          the showing is limited to much narrower, specific materials.  In            
          fact, embodiment 1 is limited to a zinc alloy powder similar to             
          that taught by Tada (see the specification, page 32).                       
               For the foregoing reasons, based on the totality of the                
          record, giving due consideration to appellants’ evidence and                
          arguments, we determine that the preponderance of evidence weighs           
          most heavily in favor of obviousness within the meaning of section          
          103.  See In re Oetiker, 977 F.2d 1443, 1445, 24 USPQ2d 1443, 1444          
          (Fed. Cir. 1992).  Accordingly, the examiner’s rejection of the             
          claims on appeal under 35 U.S.C. § 103 over Tada in view of                 
          Kawakami, Lee and Julian is affirmed.  Since we have used reasoning         
          which differs from the examiner, as well as interpreting the                
          references and construing the claims in a different manner, we              


                                         11                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007